Market Research Report: Labcorp

Company Overview

Name: Laboratory Corporation of America® Holdings (Labcorp)

Mission: To improve health and improve lives through science and innovation.

Founded: No information is available

Founders: No information is available

Key People: Dr. Prasanth Reddy, SVP, Global Enterprise Oncology Head

Headquarters: No information is available

Number of Employees: More than 60,000 globally

Revenue: No information is available

Known For: A global life sciences and healthcare company known for its advancements in diagnostics and drug development support, pioneering in genetic testing, oncology, neurology, and personalized health services.

Products

Diagnostic and Clinical Testing Services

Genetic Testing: Offers a broad range of genetic tests, including partnerships with companies like Invitae for advanced genetic insights.

Oncology Diagnostics: Includes offerings such as solid tissue biopsies and blood-based testing alternatives.

Neurological Testing: Comprehensive biomarker testing portfolio for Alzheimer's disease and other neurodegenerative disorders.

Key Products:

1. Phosphorylated Tau 217 (pTau-217), Plasma: Aids in identifying Alzheimer's pathology by detecting pTau-217 associated with amyloid pathology.

2. Beta Amyloid 42/40 Ratio, Plasma: Measures beta-amyloid proteins to provide indications of Alzheimer's disease pathology.

3. Glial Fibrillary Acidic Protein (GFAP): Predictor of Alzheimer's disease when used with amyloid pathology markers.

4. Neurofilament Light Chain, Plasma: Indicates disease severity in the context of Alzheimer's disease by measuring neurodegeneration.

Labcorp OnDemand

Description: Enables individuals to explore and order over 50 self-administered lab tests for a more informed personal health management.

Key Features: Accessibility of direct-to-consumer health tests including for cancer, neurology, and general health monitoring.

Recent Developments

New Product Launches and Enhancements

Companion Diagnostic Assay for Gastric Cancer: Recently announced availability for identifying patients eligible for treatment with VYLOY™.

Rapid Syphilis Test: Expanded STI testing offerings to include faster syphilis diagnostic options.

Partnerships and Initiatives

Invitae Partnership: Collaboration with Invitae to enhance genetic testing services.

National Birth Equity Collaborative (NBEC): Partnership with Ovia Health to promote racial equity in maternal health care.

UnitedHealthcare Children’s Foundation Partnership: Supports families through financial grants for medical expenses, with significant Labcorp contributions through sponsorships.

Key Articles and Contributions

AI in Cancer Care: Utilizing artificial intelligence to transform pap test screenings.

Biomarker Advancements: Pioneering biomarker techniques aiding Alzheimer's and other neurological disease detection.

Conclusion

This report presents Labcorp as a pivotal entity in the global life sciences and healthcare sector, with robust capabilities in diagnostics and drug development. The company’s disruption in genetic testing, oncology diagnostics, and neurological labels it as a leader in precision medicine and healthcare innovation. While data on revenue and specific founding details remain undisclosed, the company’s significant employee base and partnerships underscore its expansive influence and commitment to advancing health equity and scientific innovations.